Overview

Why attend C21 BioVentures?

---

Private Companies Building Relationships and Opportunities
Featuring presentations from 66 innovative private companies, C21 provides the right audience to help companies meet their financing goals and objectives.

Pharmaceutical Companies Building Portfolios
C21 provides pharma with a focused approach to finding the most qualified targets to partner with, giving them early access to new candidates to add to their existing product portfolios and pipelines.

Venture Capital Seeking New Opportunities for Investment
With a focus on private companies seeking investors, C21 provides excellent early stage opportunities for venture capitalists and institutional investors.


Who is attending C21 BioVentures?

---

The graphs below offer a break down on the type of companies and individuals who regularly attend C21 and make it a high value conference.

Companies: The right mix of key life science sectors


Attendees: Over 85% are key executive decision makers

• 2009 Presenters
  Click here to view a list of private companies who presented at C21 2009
  
  
• 2009 Advisory Board
  Click here to view the C21 2009 advisory board comprised of leading investment firms
  
  
• 2009 Sponsors
  Click here to view a list of sponsors from C21 2009
  
  
• 2009 Companies
  Click here to view a list of registered companies from C21 2009